• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一维和二维异核单量子相干核磁共振:区分和表征不同动物及组织来源肝素的两种方法。

1D and 2D-HSQC NMR: Two Methods to Distinguish and Characterize Heparin From Different Animal and Tissue Sources.

作者信息

Mauri Lucio, Marinozzi Maria, Phatak Nisarga, Karfunkle Michael, St Ange Kalib, Guerrini Marco, Keire David A, Linhardt Robert J

机构信息

NMR Center, Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni," Milan, Italy.

Division of Pharmaceutical Analysis, Office of Testing and Research, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, St. Louis, MO, United States.

出版信息

Front Med (Lausanne). 2019 Jun 27;6:142. doi: 10.3389/fmed.2019.00142. eCollection 2019.

DOI:10.3389/fmed.2019.00142
PMID:31316989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6610300/
Abstract

The US Food and Drug Administration has encouraged the reintroduction of bovine heparin drug product to the US market to mitigate the risks of heparin shortages and potential adulteration or contamination of the primary source which is porcine heparin. Here, a 1D-NMR method was applied to compare heparin sodium of bovine intestinal origin with that of bovine lung, porcine, or ovine intestinal origin. The results showed that a simple 1D test using NMR signal intensity ratios among diagnostic signals of the proton spectra uniquely identified the origin of heparin and concomitantly could be used to assure the correct sample labeling. However, a limitation of the use of only mono-dimensional spectra is that these spectra may not provide sufficiently detailed information on the composition of heparin batches to adequately determine the quality of this complex product. As an alternative, a higher resolution quantitative 2D-HSQC method was used to calculate the percentage of mono- and disaccharides, distinguish the origin of heparin and, simultaneously, assess the heparin composition. The 2D-HSQC method is proposed to provide sufficient information to evaluate the quality of industrial production process used to make the drug substance. Together, the 1D and 2D data produced by these measurements can be used to assure the identity and purity of this widely used drug.

摘要

美国食品药品监督管理局鼓励将牛源肝素药品重新引入美国市场,以降低肝素短缺风险以及猪源肝素这一主要来源可能存在的掺假或污染风险。在此,采用一维核磁共振(1D-NMR)方法,对牛肠源肝素钠与牛肺源、猪源或羊肠源肝素钠进行比较。结果表明,利用质子谱诊断信号的核磁共振信号强度比进行简单的一维测试,能够唯一确定肝素的来源,并可据此确保样品标签正确。然而,仅使用一维谱图存在局限性,即这些谱图可能无法提供关于肝素批次组成的足够详细信息,以充分确定这种复杂产品的质量。作为替代方法,采用更高分辨率的定量二维异核单量子相干(2D-HSQC)方法来计算单糖和二糖的百分比、区分肝素来源,同时评估肝素组成。二维异核单量子相干方法被认为能够提供足够信息,以评估用于生产原料药的工业生产过程的质量。这些测量产生的一维和二维数据共同可用于确保这种广泛使用的药物的同一性和纯度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8a/6610300/31dde146c4c7/fmed-06-00142-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8a/6610300/c95ad20bd935/fmed-06-00142-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8a/6610300/f52153ec19ac/fmed-06-00142-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8a/6610300/82161fa5bfc2/fmed-06-00142-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8a/6610300/7f29107190ad/fmed-06-00142-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8a/6610300/4acdfbcd64a2/fmed-06-00142-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8a/6610300/dbae1585929c/fmed-06-00142-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8a/6610300/31dde146c4c7/fmed-06-00142-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8a/6610300/c95ad20bd935/fmed-06-00142-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8a/6610300/f52153ec19ac/fmed-06-00142-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8a/6610300/82161fa5bfc2/fmed-06-00142-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8a/6610300/7f29107190ad/fmed-06-00142-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8a/6610300/4acdfbcd64a2/fmed-06-00142-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8a/6610300/dbae1585929c/fmed-06-00142-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a8a/6610300/31dde146c4c7/fmed-06-00142-g0007.jpg

相似文献

1
1D and 2D-HSQC NMR: Two Methods to Distinguish and Characterize Heparin From Different Animal and Tissue Sources.一维和二维异核单量子相干核磁共振:区分和表征不同动物及组织来源肝素的两种方法。
Front Med (Lausanne). 2019 Jun 27;6:142. doi: 10.3389/fmed.2019.00142. eCollection 2019.
2
Authentication of animal origin of heparin and low molecular weight heparin including ovine, porcine and bovine species using 1D NMR spectroscopy and chemometric tools.采用一维 NMR 光谱和化学计量学工具鉴定肝素和低分子量肝素的动物来源,包括羊、猪和牛物种。
J Pharm Biomed Anal. 2018 Feb 5;149:114-119. doi: 10.1016/j.jpba.2017.10.020. Epub 2017 Oct 27.
3
Improving reliability of chemometric models for authentication of species origin of heparin by switching from 1D to 2D NMR experiments.通过从一维到二维 NMR 实验的转变来提高肝素物种起源化学计量模型的可靠性。
J Pharm Biomed Anal. 2018 May 10;153:168-174. doi: 10.1016/j.jpba.2018.02.041.
4
SAX-HPLC and HSQC NMR Spectroscopy: Orthogonal Methods for Characterizing Heparin Batches Composition.二维液相色谱和异核单量子相干核磁共振波谱法:用于表征肝素批次组成的正交方法。
Front Med (Lausanne). 2019 Apr 18;6:78. doi: 10.3389/fmed.2019.00078. eCollection 2019.
5
2D NMR peak profiling to compare chemical differences between batches of pentosan polysulfate sodium.2D NMR 峰形分析比较戊聚糖多硫酸钠批次间的化学差异。
J Pharm Biomed Anal. 2022 Mar 20;211:114589. doi: 10.1016/j.jpba.2022.114589. Epub 2022 Jan 11.
6
Qualification of HSQC methods for quantitative composition of heparin and low molecular weight heparins.用于肝素和低分子肝素定量组成分析的HSQC方法的验证
J Pharm Biomed Anal. 2017 Mar 20;136:92-105. doi: 10.1016/j.jpba.2016.12.031. Epub 2016 Dec 26.
7
Combining NMR Spectroscopy and Chemometrics to Monitor Structural Features of Crude Hep-arin.结合核磁共振光谱法和化学计量学监测粗肝素的结构特征。
Molecules. 2017 Jul 8;22(7):1146. doi: 10.3390/molecules22071146.
8
Combining 1H NMR spectroscopy and multivariate regression techniques to quantitatively determine falsification of porcine heparin with bovine species.结合核磁共振氢谱和多元回归技术定量测定猪肝素中牛源性掺假成分。
J Pharm Biomed Anal. 2015 Nov 10;115:543-51. doi: 10.1016/j.jpba.2015.08.017. Epub 2015 Aug 18.
9
(1)H NMR signal at 2.10 ppm in the spectrum of KMnO(4)-bleached heparin sodium: identification of the chemical origin using an NMR-only approach.(1)KMnO(4)-次肝素钠光谱中 2.10 ppm 的 1H NMR 信号:仅使用 NMR 方法鉴定化学起源。
Anal Bioanal Chem. 2011 Jan;399(2):621-8. doi: 10.1007/s00216-010-4177-7. Epub 2010 Nov 11.
10
GIPMA: Global Intensity-Guided Peak Matching and Alignment for 2D H-C HSQC-Based Metabolomics.GIPMA:基于二维 H-C HSQC 的代谢组学的全局强度引导峰匹配和对齐
Anal Chem. 2023 Feb 14;95(6):3195-3203. doi: 10.1021/acs.analchem.2c03323. Epub 2023 Feb 2.

引用本文的文献

1
Butyrate Increases Heparin Synthesis and Storage in Human Mast Cells.丁酸盐增加人肥大细胞中的肝素合成和储存。
Cells. 2024 Jul 24;13(15):1241. doi: 10.3390/cells13151241.
2
A Unique Enoxaparin Derived from Bovine Intestinal Heparin: A Single Purification Step of the Starting Material Assures a Bovine Enoxaparin Like the Standard from Porcine Origin.一种源自牛肠肝素的独特依诺肝素:起始原料的单一纯化步骤确保了一种类似猪源标准品的牛依诺肝素。
ACS Omega. 2024 May 10;9(21):23111-23120. doi: 10.1021/acsomega.4c02128. eCollection 2024 May 28.
3
Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin.

本文引用的文献

1
Qualification of HSQC methods for quantitative composition of heparin and low molecular weight heparins.用于肝素和低分子肝素定量组成分析的HSQC方法的验证
J Pharm Biomed Anal. 2017 Mar 20;136:92-105. doi: 10.1016/j.jpba.2016.12.031. Epub 2016 Dec 26.
2
Quantitative analysis of the major linkage region tetrasaccharides in heparin.肝素主要连接区四糖的定量分析。
Carbohydr Polym. 2017 Feb 10;157:244-250. doi: 10.1016/j.carbpol.2016.09.081. Epub 2016 Sep 29.
3
Structural and haemostatic features of pharmaceutical heparins from different animal sources: challenges to define thresholds separating distinct drugs.
化学合成和生物学方法制备与猪源产品类似的生物工程肝素,并可转化为低分子量肝素。
Proc Natl Acad Sci U S A. 2024 Apr 2;121(14):e2315586121. doi: 10.1073/pnas.2315586121. Epub 2024 Mar 18.
4
Approaches to Assure Similarity between Pharmaceutical Heparins from Two Different Manufacturers.确保来自两个不同制造商的药用肝素之间相似性的方法。
Pharmaceutics. 2023 Mar 31;15(4):1115. doi: 10.3390/pharmaceutics15041115.
5
Glycosaminoglycans: What Remains To Be Deciphered?糖胺聚糖:还有哪些有待破解?
JACS Au. 2023 Mar 2;3(3):628-656. doi: 10.1021/jacsau.2c00569. eCollection 2023 Mar 27.
6
Heparan sulfates and heparan sulfate binding proteins in sepsis.脓毒症中的硫酸乙酰肝素及硫酸乙酰肝素结合蛋白
Front Mol Biosci. 2023 Feb 14;10:1146685. doi: 10.3389/fmolb.2023.1146685. eCollection 2023.
7
Anticoagulant Activity of Heparins from Different Animal Sources are Driven by a Synergistic Combination of Physical-chemical Factors.不同动物来源肝素的抗凝活性受物理化学因素协同组合的驱动。
TH Open. 2022 Oct 11;6(4):e309-e322. doi: 10.1055/a-1946-0325. eCollection 2022 Oct.
8
Heparinase Digestion of 3--Sulfated Sequences: Selective Heparinase II Digestion for Separation and Identification of Binding Sequences Present in ATIII Affinity Fractions of Bovine Intestinal Heparins.3 - 硫酸化序列的肝素酶消化:用于分离和鉴定牛肠肝素抗凝血酶III亲和级分中存在的结合序列的选择性肝素酶II消化
Front Med (Lausanne). 2022 Mar 31;9:841726. doi: 10.3389/fmed.2022.841726. eCollection 2022.
9
General Considerations for Diversifying Heparin Drug Products by Improving the Current Heparin Manufacturing Process and Reintroducing Bovine Sourced Heparin to the US Market.通过改进现有的肝素生产工艺和重新向美国市场引入牛源肝素,多样化肝素药物产品的一般考虑。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211052293. doi: 10.1177/10760296211052293.
10
Specific Non-Reducing Ends in Heparins from Different Animal Origins: Building Blocks Analysis Using Reductive Amination Tagging by Sulfanilic Acid.不同动物源肝素中的特定非还原末端:用磺酰苯胺进行还原胺化标记的构建块分析。
Molecules. 2020 Nov 26;25(23):5553. doi: 10.3390/molecules25235553.
不同动物源药物肝素的结构和止血特性:定义区分不同药物的阈值的挑战。
Sci Rep. 2016 Oct 18;6:35619. doi: 10.1038/srep35619.
4
The US regulatory and pharmacopeia response to the global heparin contamination crisis.美国针对全球肝素污染危机的监管及药典应对措施。
Nat Biotechnol. 2016 Jun 9;34(6):625-30. doi: 10.1038/nbt.3606.
5
Structural peculiarity and antithrombin binding region profile of mucosal bovine and porcine heparins.黏膜牛肝素和猪肝素的结构特性及抗凝血酶结合区域图谱
J Pharm Biomed Anal. 2016 Jan 25;118:52-63. doi: 10.1016/j.jpba.2015.10.001. Epub 2015 Oct 17.
6
Identification of a novel structure in heparin generated by potassium permanganate oxidation.高锰酸钾氧化生成的肝素中一种新结构的鉴定。
Carbohydr Polym. 2010 Oct 15;82(3):699-705. doi: 10.1016/j.carbpol.2010.05.038.
7
Structural characterization of pharmaceutical heparins prepared from different animal tissues.不同动物组织来源的药用肝素的结构特征分析。
J Pharm Sci. 2013 May;102(5):1447-57. doi: 10.1002/jps.23501. Epub 2013 Mar 21.
8
Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.牛肠黏膜肝素:具有多种硫酸化模式和抗凝作用的聚糖。
Thromb Haemost. 2012 May;107(5):903-15. doi: 10.1160/TH-11-07-0518. Epub 2012 Mar 22.
9
Construction and use of a library of bona fide heparins employing 1H NMR and multivariate analysis.采用 1H NMR 和多元分析构建和使用真实肝素文库。
Analyst. 2011 Apr 7;136(7):1380-9. doi: 10.1039/c0an00834f. Epub 2011 Jan 31.
10
Heparins from porcine and bovine intestinal mucosa: Are they similar drugs?猪肠和牛肠黏膜来源肝素:它们是类似的药物吗?
Thromb Haemost. 2010 May;103(5):1005-15. doi: 10.1160/TH09-11-0761. Epub 2010 Mar 9.